Cat.#: ACPP-1296
| Despition | Fibroblast Growth Factor-19 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Filtered white lyophilized powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
| ACPP-1304 | Netrin 1 Blocking Peptide (AC1304) | 250 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1407 | Human HOMER3 Protein (AC1407) | 5 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1720 | Human PNPO Protein (AC1720) | 5 µg | inquiry |
| ACPP-1765 | Human PQBP1 Protein (AC1765) | 5 µg | inquiry |
| ACPP-1785 | Human NEUROG3 Protein (AC1785) | 2 µg | inquiry |
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.